Atlas Trials

Safety and Efficacy of QBECO in Moderate to Severe Ulcerative Colitis

Clinical trial NCT02426372 · COMPLETED

Trial details

NCT number
NCT02426372
Sponsor
Qu Biologics Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2015-07-01
Primary completion
2016-12-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.